Interleukin-2 Transiently Inhibits Pulsatile Growth Hormone Secretion in Young but not Older Healthy Men

Autor: Rebecca Yang, Johannes D. Veldhuis, Ferdinand Roelfsema
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Adult
Male
0301 basic medicine
medicine.medical_specialty
Time Factors
Adolescent
Injections
Subcutaneous

Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
Clinical Biochemistry
Pulsatile flow
030209 endocrinology & metabolism
Context (language use)
Biochemistry
Proinflammatory cytokine
Young Adult
03 medical and health sciences
Subcutaneous injection
0302 clinical medicine
Endocrinology
Double-Blind Method
Internal medicine
medicine
Humans
Prospective Studies
Saline
Aged
Aged
80 and over

Clinical Research Article
Cross-Over Studies
Secretory Pathway
business.industry
interleukin
Biochemistry (medical)
Age Factors
Interleukin
Middle Aged
Crossover study
Healthy Volunteers
Growth hormone secretion
cytokines
030104 developmental biology
inflammation
growth hormone
Interleukin-2
business
Zdroj: Journal of Clinical Endocrinology and Metabolism, 106(10), 2855-2864. ENDOCRINE SOC
J Clin Endocrinol Metab
Popis: Context Interleukin-2 (IL-2), a proinflammatory cytokine, has been used to treat malignancies. Increased cortisol and adrenocorticotropin (ACTH) were noted, but growth hormone (GH) secretion was not investigated in detail. Objective We quantified GH secretion after a single subcutaneous injection of IL-2 in 17 young and 18 older healthy men in relation to dose, age, and body composition. Methods This was a placebo-controlled, blinded, prospectively randomized, crossover study. At 20:00 hours IL-2 (3 or 6 million units/m2) or saline was injected subcutaneously. Lights were off between 23:00 and 07:00 hours. Blood was sampled at 10-minute intervals for 24 hours. Outcome measures included convolution analysis of GH secretion. Results GH profiles were pulsatile under both experimental conditions and lower in older than young volunteers. Since the effect of IL-2 might be time limited, GH analyses were performed on the complete 24-hour series and the 6 hours after IL-2 administration. Total and pulsatile 24-hour GH secretion decreased nonsignificantly. Pulsatile secretion fell over the first 6 hours after IL-2 (P = .03), with visceral fat as a covariate (P = .003), but not age (P = .10). Plots of cumulative 2-hour bins of GH pulse mass showed a distinction by treatment and age groups: A temporary GH decrease of 32% and 28% occurred in the first 2-hour bins after midnight (P = .02 and .04) in young participants, whereas in older individuals no differences were present at any time point. Conclusion This study demonstrates that IL-2 temporarily diminishes GH secretion in young, but not older, men.
Databáze: OpenAIRE